A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study - Santoro, A.; Gebbia, V.; Pressiani, T.; Testa, A.; Personeni, N.; Arrivas Bajardi, E.; Foa, P.; Buonadonna, A.; Bencardino, K.; Barone, C.; Ferrari, D.; Zaniboni, A.; et al. (Annals of oncology, 2015)
Keywords: advanced biliary tract cancer; Aged; Antineoplastic Combined Chemotherapy Protocols - administration & dosage; Biliary Tract Neoplasms - diagnosis; Biliary Tract Neoplasms - drug therapy; Deoxycytidine - administration & dosage; Deoxycytidine - analogs & derivatives; Double-Blind Method; Female; gemcitabine; Humans; Male; Middle Aged; Piperidines - administration & dosage; Quinazolines - administration & dosage; vandetanib; vandetanib; advanced biliary tract cancer; gemcitabine